Clinical Trial Update: Abbreviated 3 Cycles of Rituximab Plus CHOP(Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) Immunochemotherapy in Patients With Completely Excised LocalizedGastrointestinal CD(Cluster of Differentiation Antigen)20(+) Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating abbreviated 3-cycle Rituximab plus CHOP immunochemotherapy in completely resected localized CD20+ diffuse large B-cell lymphoma (DLBCL)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituximab plus CHOP immunochemotherapy

Snippet

Sponsor: Asan Medical Center | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: UNKNOWN